Supplementary Figure 3 from Unbiased Compound Screening Identifies Unexpected Drug Sensitivities and Novel Treatment Options for Gastrointestinal Stromal Tumors

crossref(2023)

引用 0|浏览8
暂无评分
摘要

PDF - 1670K, Inhibitors of transcription and of topoisomerase II are effective in imatinib-/sunitinib-double-resistant primary GIST cells and GIST xenograft models.

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要